Terms: = Lung cancer AND PAM50
15 results:
1. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
Dieci MV; Conte P; Bisagni G; Bartolini S; Frassoldati A; Generali D; Piacentini F; Griguolo G; Tagliafico E; Brasó Maristany F; Chic N; Paré L; Miglietta F; Vicini R; D'Amico R; Balduzzi S; Prat A; Guarneri V
J Natl Cancer Inst; 2024 Jan; 116(1):69-80. PubMed ID: 37676829
[TBL] [Abstract] [Full Text] [Related]
2. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Subtyping of Invasive Breast cancer Using a pam50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Erber R; Angeloni M; Stöhr R; Lux MP; Ulbrich-Gebauer D; Pelz E; Bankfalvi A; Schmid KW; Walter RFH; Vetter M; Thomssen C; Mayr D; Klauschen F; Sinn P; Sotlar K; Stering K; Stenzinger A; Wunderle M; Fasching PA; Beckmann MW; Hoffmann O; Kimmig R; Harbeck N; Wuerstlein R; Ferrazzi F; Hartmann A
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955851
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases.
Ruan H; Wang Z; Sun Z; Wei J; Zhang L; Ju H; Wang T; Zhang C; Guan M; Pan S
Clin Transl Med; 2022 Jun; 12(6):e885. PubMed ID: 35678121
[TBL] [Abstract] [Full Text] [Related]
5. NRF2 drives an oxidative stress response predictive of breast cancer.
Wolowczyk C; Neckmann U; Aure MR; Hall M; Johannessen B; Zhao S; Skotheim RI; Andersen SB; Zwiggelaar R; Steigedal TS; Lingjærde OC; Sahlberg KK; Almaas E; Bjørkøy G
Free Radic Biol Med; 2022 May; 184():170-184. PubMed ID: 35381325
[TBL] [Abstract] [Full Text] [Related]
6. The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy.
Grass GD; Alfonso JCL; Welsh E; Ahmed KA; Teer JK; Pilon-Thomas S; Harrison LB; Cleveland JL; Mulé JJ; Eschrich SA; Enderling H; Torres-Roca JF
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):635-647. PubMed ID: 35289298
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the ERβ/HER Oncogenic Network in
Almotlak AA; Farooqui M; Soloff AC; Siegfried JM; Stabile LP
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008514
[TBL] [Abstract] [Full Text] [Related]
8. The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling.
Schlam I; Church SE; Hether TD; Chaldekas K; Hudson BM; White AM; Maisonet E; Harris BT; Swain SM
J Transl Med; 2021 Nov; 19(1):480. PubMed ID: 34838031
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression profiles of breast cancer metastasis according to organ site.
Brasó-Maristany F; Paré L; Chic N; Martínez-Sáez O; Pascual T; Mallafré-Larrosa M; Schettini F; González-Farré B; Sanfeliu E; Martínez D; Galván P; Barnadas E; Salinas B; Tolosa P; Ciruelos E; Carcelero E; Guillén C; Adamo B; Moreno R; Vidal M; Muñoz M; Prat A
Mol Oncol; 2022 Jan; 16(1):69-87. PubMed ID: 34051058
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor.
Nacer DF; Liljedahl H; Karlsson A; Lindgren D; Staaf J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971670
[TBL] [Abstract] [Full Text] [Related]
11. Galgo: a bi-objective evolutionary meta-heuristic identifies robust transcriptomic classifiers associated with patient outcome across multiple cancer types.
Guerrero-Gimenez ME; Fernandez-Muñoz JM; Lang BJ; Holton KM; Ciocca DR; Catania CA; Zoppino FCM
Bioinformatics; 2020 Dec; 36(20):5037-5044. PubMed ID: 32638009
[TBL] [Abstract] [Full Text] [Related]
12. Expression of pam50 Genes in lung cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
[TBL] [Abstract] [Full Text] [Related]
13. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
Avraham A; Cho SS; Uhlmann R; Polak ML; Sandbank J; Karni T; Pappo I; Halperin R; Vaknin Z; Sella A; Sukumar S; Evron E
PLoS One; 2014; 9(3):e91805. PubMed ID: 24651077
[TBL] [Abstract] [Full Text] [Related]
14. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.
Drews-Elger K; Brinkman JA; Miller P; Shah SH; Harrell JC; da Silva TG; Ao Z; Schlater A; Azzam DJ; Diehl K; Thomas D; Slingerland JM; Perou CM; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2014 Apr; 144(3):503-17. PubMed ID: 24567196
[TBL] [Abstract] [Full Text] [Related]
15. Genetic background may contribute to pam50 gene expression breast cancer subtype assignments.
Hu Y; Bai L; Geiger T; Goldberger N; Walker RC; Green JE; Wakefield LM; Hunter KW
PLoS One; 2013; 8(8):e72287. PubMed ID: 24015230
[TBL] [Abstract] [Full Text] [Related]